An interventional study of Control and Pecan in Healthy, sponsored by University of Georgia. Completed at 1 site in United States. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-04-20.
Sponsored by University of Georgia · Not applicable, Interventional, and Other
Pecans are a nutrient-dense food, but it is unknown whether substituting pecans for a portion of the butter in a traditional breakfast meal improves post-meal responses.
This study was a randomized, double-blind control trial consisting of 2 study visits for 2 different treatments. The treatments were high-fat breakfast muffins containing either butter (control) or pecans. The investigators recruited healthy, normal-weight adults between the ages of 15 and 45y. Study visits were completed in a random order with at least 72 hours between each visit. Anthropometrics, questionnaires, and fasting and postprandial blood samples were collected at each visit.
Hypothesis: The pecan-enriched meal will blunt the post-meal increase in glucose, insulin, triglycerides (TG), and lipid peroxidation while improving all measures of subjective appetite and TAC compared to the traditional meal without nuts.
University of Georgia is the lead sponsor of 72 studies on the registry; 16 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Participants in this group received a traditional muffin with butter as the predominant source of fat.
Other: Control
Participants in this group received a muffin in which part of the butter was substituted out for pecans.
Other: Pecan
Participants in this group received a traditional muffin with butter as the predominant source of fat.
Participants in this group received a muffin in which part of the butter was substituted out for pecans.
Change in triglycerides (TG) and glucose
TG (mg/dL) and glucose (mg/dL)
Time frame: Change from baseline to 3 hours postprandially
Change in lipid peroxidation
Malondialdehyde (MDA) (uM) measured via Thiobarbituric acid reactive substances (TBARS) assay
Time frame: Change from baseline to 3 hours postprandially
Change in total antioxidant capacity
Total antioxidant capacity (uM trolox equivalents) measured via Oxygen Radical Absorbance Capacity (ORAC) assay.
Time frame: Change from baseline to 3 hours postprandially
Change in insulin
Insulin (uU/mL)
Time frame: Change from baseline to 3 hours postprandially
Change in angiopoietin-like proteins-3 (ANGPTL3) and -4 (ANGPTL4) responses
ANGPTL3 (pg/mL) and ANGPTL4 (pg/mL)
Time frame: Change from baseline to 3 hours postprandially
Change in hunger and satiety responses
Hunger, fullness, prospective consumption, and desire to eat measured via a Visual Analog Scale (VAS) (mm). The range of scores on the continuous VAS is 0-100 mm. Zero represents no hunger, fullness, prospective consumption, and desire to eat, while 100 represents the greatest feeling of these outcomes.
Time frame: Change from baseline to 3 hours postprandially
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Georgia